Blueprint





 







Exhibit 4.3



 


Warrant
Certificate No. PAW- __


 


NEITHER
THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES
ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“ACT”), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH
SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, ASSIGNED
OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH
RESPECT THERETO IS EFFECTIVE UNDER THE ACT AND ANY APPLICABLE STATE
SECURITIES LAWS, OR (2) AN EXEMPTION FROM SUCH REGISTRATION EXISTS
AND THE COMPANY RECEIVES AN OPINION OF COUNSEL TO THE HOLDER OF
SUCH SECURITIES, WHICH COUNSEL AND OPINION ARE SATISFACTORY TO THE
COMPANY, THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED,
ASSIGNED OR TRANSFERRED IN THE MANNER CONTEMPLATED WITHOUT AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR APPLICABLE STATE
SECURITIES LAWS.


 


 




 


	
 Effective Date:
April 8, 2016

	
 Void After: April
8, 2021











 



ADGERO BIOPHARMACEUTICALS HOLDINGS, INC.


 


WARRANT
TO PURCHASE COMMON STOCK


 


Adgero Biopharmaceuticals Holdings,
Inc., a Delaware corporation (the “Company”), for value received on
July 29, 2016 (the “Effective
Date”), hereby issues to [ ] (the “Holder” or “Warrant Holder”) this Warrant (the
“Warrant”) to
purchase, [ ] shares (each
such share as from time to time adjusted as hereinafter provided
being a “Warrant
Share” and all such shares being the
“Warrant
Shares”) of the Company’s Common Stock (as
defined below), at the Exercise Price (as defined below), as
adjusted from time to time as provided herein, on or before April
8, 2021 (the “Expiration
Date”), all subject to the following terms and
conditions. This Warrant is one of a series of placement agent
warrants of like tenor that have been issued in connection with the
Company’s private offering of securities pursuant to the
terms of that certain Confidential Private Placement Memorandum of
the Company dated January 11, 2016, as the same may have been
amended and supplemented from time to time and the Placement Agency
Agreement dated January 11, 2016, by and between Aegis Capital
Corp., Adgero Biopharmaceuticals, Inc. and the Company as the same
may have been amended from time to time.


 


As used
in this Warrant, (i) “Business Day” means any day other
than Saturday, Sunday or any other day on which commercial banks in
the City of New York, New York, are authorized or required by law
or executive order to close; (ii) “Common Stock” means the common
stock of the Company, par value $0.0001 per share, including any
securities issued or issuable with respect thereto or into which or
for which such shares may be exchanged for, or converted into,
pursuant to any stock dividend, stock split, stock combination,
recapitalization, reclassification, reorganization or other similar
event; (iii) “Exercise
Price” means $5.00
per share of Common Stock, subject to adjustment as provided
herein; (iv) “Trading
Day” means any day on which the Common Stock is traded
(or available for trading) on its principal trading
market; and (v)
“Affiliate” means any person that, directly or
indirectly, through one or more intermediaries, controls, is
controlled by, or is under common control with, a person, as such
terms are used and construed in Rule 144 promulgated under the
Securities Act of 1933, as amended (the “Securities
Act”).


 



 

1







 






 


1.    DURATION AND EXERCISE OF
WARRANTS


 


(a)    Exercise
Period. The Holder may exercise
this Warrant in whole or in part on any Business Day on or before
5:00 P.M., Eastern Time, on the Expiration Date, at which time this
Warrant shall become void and of no value.


 


(b)    Exercise
Procedures.


 


(i)    While this Warrant remains outstanding and
exercisable in accordance with Section 1(a), in addition to the
manner set forth in Section 1(b)(ii) below, the Holder may exercise
this Warrant in whole or in part at any time and from time to time
by:


 


(A)    delivery to the Company of a duly executed copy of
the Notice of Exercise attached as Exhibit A;


 


(B)    surrender of this Warrant to the Secretary of the
Company at its principal offices or at such other office or agency
as the Company may specify in writing to the Holder;
and


 


(C)    payment of the then-applicable Exercise Price per
share multiplied by the number of Warrant Shares being purchased
upon exercise of the Warrant (such amount, the
“Aggregate Exercise
Price”) made in the form
of cash, or by certified check, bank draft or money order payable
in lawful money of the United States of America or in the form of a
Cashless Exercise to the extent permitted in Section 1(b)(ii)
below.


 


(ii)    At any time, the Holder may, in its sole
discretion, exercise all or any part of the Warrant in a
“cashless” or “net-issue” exercise (a
“Cashless
Exercise”) by delivering
to the Company (1) the Notice of Exercise and (2) the original
Warrant, pursuant to which the Holder shall surrender the right to
receive upon exercise of this Warrant, a number of Warrant Shares
having a value (as determined below) equal to the Aggregate
Exercise Price, in which case, the number of Warrant Shares to be
issued to the Holder upon such exercise shall be calculated using
the following formula:









X              =              Y
* (A - B)


       A


 


	
 

	
with:

	
X=

	
 the number of Warrant Shares to be issued to the
Holder


	
 

	
 

	
 

	
 


	
 

	
 

	
Y=

	
 the
number of Warrant Shares with respect to which the Warrant is being
exercised


	
 

	
 

	
 

	
 


	
 

	
 

	
A=

	
 the
fair value per share of Common Stock on the date of exercise of
this Warrant


	
 

	
 

	
 

	
 


	
 

	
 

	
B=

	
 the then-current Exercise Price of the
Warrant






  



 





 

2







 






 


Solely for the purposes of this paragraph,
“fair
value” per share of
Common Stock shall mean the average Closing Price (as defined
below) per share of Common Stock for the twenty (20) trading days
immediately preceding the date on which the Notice of Exercise is
deemed to have been sent to the Company. “Closing
Price” means, for any
date, the price determined by the first of the following clauses
that applies:  (a) if the Common Stock is then listed or
quoted on the New York Stock Exchange, the NYSE MKT, the NASDAQ
Global Select Market, the NASDAQ Global Market or the NASDAQ
Capital Market or any other national securities exchange, the
closing price per share of the Common Stock for such date (or the
nearest preceding date) on the primary eligible market or exchange
on which the Common Stock is then listed or quoted; (b) if prices
for the Common Stock are then quoted on the OTC Bulletin Board or
any tier of the OTC Markets, the closing bid price per share of the
Common Stock for such date (or the nearest preceding date) so
quoted; or (c) if prices for the Common Stock are then reported in
the “Pink Sheets” published by the National Quotation
Bureau Incorporated (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent closing bid
price per share of the Common Stock so reported. If the Common
Stock is not publicly traded as set forth above, the “fair
value” per share of Common Stock shall be reasonably and in
good faith determined by the Board of Directors of the Company as
of the date which the Notice of Exercise is deemed to have been
sent to the Company.


 


For
purposes of Rule 144 promulgated under the Securities Act, it is
intended, understood and acknowledged that the Warrant Shares
issued in a cashless exercise transaction shall be deemed to have
been acquired by the Holder, and the holding period for such shares
shall be deemed to have commenced, on the Effective Date of this
Warrant.


 


(iii)           Upon
the exercise of this Warrant in compliance with the provisions of
this Section 1(b), and except as limited pursuant to the last
paragraph of Section 1(b)(ii), the Company shall promptly issue and
cause to be delivered to the Holder a certificate for the Warrant
Shares purchased by the Holder. Each exercise of this Warrant shall
be effective immediately prior to the close of business on the date
(the “Date of
Exercise”) that the
conditions set forth in Section 1(b) have been satisfied, as the
case may be. On the first Business Day following the date on which
the Company has received each of the Notice of Exercise and the
Aggregate Exercise Price (or notice of a Cashless Exercise in
accordance with Section 1(b)(ii)) (the “Exercise Delivery
Documents”), the Company
shall transmit an acknowledgment of receipt of the Exercise
Delivery Documents to the Company’s transfer agent (the
“Transfer
Agent”). On or before the
third Business Day following the date on which the Company has
received all of the Exercise Delivery Documents (the
“Share
Delivery Date”), the
Company shall (X) provided that the Transfer Agent is participating
in The Depository Trust Company (“DTC”) Fast Automated Securities Transfer
Program, upon the request of the Holder, credit such aggregate
number of shares of Common Stock to which the Holder is entitled
pursuant to such exercise to the Holder’s or its
designee’s balance account with DTC through its Deposit
Withdrawal Agent Commission system, or (Y) if the Transfer Agent is
not participating in the DTC Fast Automated Securities Transfer
Program, issue and dispatch by overnight courier to the address as
specified in the Notice of Exercise, a certificate, registered in
the Company’s share register in the name of the Holder or its
designee, for the number of shares of Common Stock to which the
Holder is entitled pursuant to such exercise. Upon delivery of the
Exercise Delivery Documents, the Holder shall be deemed for all
corporate purposes to have become the holder of record of the
Warrant Shares with respect to which this Warrant has been
exercised, irrespective of the date of delivery of the certificates
evidencing such Warrant Shares.


 



 

3







 






 


(iv)           If
the Company shall fail for any reason or for no reason to issue to
the Holder, within three (3) Business Days of receipt of the
Exercise Delivery Documents, a certificate for the number of shares
of Common Stock to which the Holder is entitled and register such
shares of Common Stock on the Company’s share register or to
credit the Holder’s balance account with DTC for such number
of shares of Common Stock to which the Holder is entitled upon the
Holder’s exercise of this Warrant, and if on or after such
Business Day the Holder purchases (in an open market transaction or
otherwise) shares of Common Stock to deliver in satisfaction of a
sale by the Holder of shares of Common Stock issuable upon such
exercise that the Holder anticipated receiving from the Company (a
“Buy-In”), then the Company shall, (A) pay in cash
to the Holder the amount, if any, by which (x) the Holder’s
total purchase price (including brokerage commissions, if any) for
the shares of Common Stock so purchased (the
“Buy-In
Amount”) plus the amount
paid by the Holder to the Company as the exercise price for the
Warrant Shares exceeds (y) the amount obtained by multiplying (1)
the number of Warrant Shares that the Company was required to
deliver to the Holder in connection with the exercise at issue
times (2) the price at which the sell order giving rise to such
purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent
number of Warrant Shares for which such exercise was not honored or
deliver to the Holder the number of shares of Common Stock that
would have been issued had the Company timely complied with its
exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of
$11,000 to cover a Buy-In with respect to an attempted exercise of
shares of Common Stock, and paid the Company $5,000 as the exercise
price, the Holder’s cash outlay would be a total of $16,000;
and if the aggregate sales price of the shares giving rise to such
Buy-In obligation was $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder
$6,000. The Holder shall provide the Company written notice
indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of
such loss. Nothing herein shall limit a Holder’s right to
pursue any other remedies available to it hereunder, at law or in
equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the
Company’s failure to timely deliver certificates representing
shares of Common Stock upon exercise of the Warrant as required
pursuant to the terms hereof.


 


(c)           Partial
Exercise. This Warrant shall be
exercisable, either in its entirety or, from time to time, for part
only of the number of Warrant Shares referenced by this Warrant. If
this Warrant is submitted in connection with any exercise pursuant
to Section 1 and the number of Warrant Shares represented by this
Warrant submitted for exercise is greater than the actual number of
Warrant Shares being acquired upon such an exercise, then the Company shall as soon as
practicable and in no event later than five (5) Business Days after
any exercise and at its own expense, issue a new Warrant of like
tenor representing the right to purchase the number of Warrant
Shares purchasable immediately prior to such exercise under this
Warrant, less the number of Warrant Shares with respect to which
this Warrant is exercised.


 



 

4







 






 


(d)    Disputes.
In the case of a dispute as to the determination of the Exercise
Price or the arithmetic calculation of the Warrant Shares, the
Company shall promptly issue to the Holder the number of Warrant
Shares that are not disputed and resolve such dispute in accordance
with Section 16.


 


2.    ISSUANCE OF WARRANT SHARES


 


(a)    The Company covenants that all Warrant Shares
will, upon issuance in accordance with the terms of this Warrant,
be (i) duly authorized, fully paid and non-assessable, and (ii)
free from all liens, charges and security interests, with the
exception of claims arising through the acts or omissions of any
Holder and except as arising from applicable Federal and state
securities laws.


 


(b)    The Company shall register this Warrant upon
records to be maintained by the Company for that purpose in the
name of the record holder of such Warrant from time to time. The
Company may deem and treat the registered Holder of this Warrant as
the absolute owner thereof for the purpose of any exercise thereof,
any distribution to the Holder thereof and for all other
purposes.


 


(c)    The Company will not, by amendment of its
certificate of incorporation, by-laws or through any
reorganization, transfer of assets, consolidation, merger,
dissolution, issue or sale of securities or any other voluntary
action, avoid or seek to avoid the observance or performance of any
of the terms to be observed or performed hereunder by the Company,
but will at all times in good faith assist in the carrying out of
all the provisions of this Warrant and in the taking of all action
necessary or appropriate in order to protect the rights of the
Holder to exercise this Warrant, or against impairment of such
rights.


 



3.    ADJUSTMENTS OF EXERCISE PRICE, NUMBER AND TYPE OF
WARRANT SHARES


 


(a)    The Exercise Price and the
number of shares purchasable upon the exercise of this Warrant
shall be subject to adjustment from time to time upon the
occurrence of certain events described in this Section 3;
provided,
that notwithstanding the provisions of this Section 3, the Company
shall not be required to make any adjustment if and to the extent
that such adjustment would require the Company to issue a number of
shares of Common Stock in excess of its authorized but unissued
shares of Common Stock, less all amounts of Common Stock that have
been reserved for issue upon the conversion of all outstanding
securities convertible into shares of Common Stock and the exercise
of all outstanding options, warrants and other rights exercisable
for shares of Common Stock. If the Company does not have the
requisite number of authorized but unissued shares of Common Stock
to make any adjustment, the Company shall use its commercially best
efforts to obtain the necessary stockholder consent to increase the
authorized number of shares of Common Stock to make such an
adjustment pursuant to this Section 3.


 



 

5







 






 


(i)    Subdivision or
Combination of Stock. In case
the Company shall at any time subdivide (whether by way of stock
dividend, stock split or otherwise) its outstanding shares of
Common Stock into a greater number of shares, the Exercise Price in
effect immediately prior to such subdivision shall be
proportionately reduced and the number of Warrant Shares shall be
proportionately increased, and conversely, in case the outstanding
shares of Common Stock of the Company shall be combined (whether by
way of stock combination, reverse stock split or otherwise) into a
smaller number of shares, the Exercise Price in effect immediately
prior to such combination shall be proportionately increased and
the number of Warrant Shares shall be proportionately decreased.
The Exercise Price and the Warrant Shares, as so adjusted, shall be
readjusted in the same manner upon the happening of any successive
event or events described in this Section
3(a)(i).


 


(ii)    Dividends in Stock,
Property, Reclassification. If
at any time, or from time to time, all of the holders of Common
Stock (or any shares of stock or other securities at the time
receivable upon the exercise of this Warrant) shall have received
or become entitled to receive, without payment
therefore:


 


(A)    any shares of stock or other securities that are
at any time directly or indirectly convertible into or exchangeable
for Common Stock, or any rights or options to subscribe for,
purchase or otherwise acquire any of the foregoing by way of
dividend or other distribution, or


 


(B)   additional stock or other securities or property
(including cash) by way of spin-off, split-up, reclassification,
combination of shares or similar corporate rearrangement (other
than shares of Common Stock issued as a stock split or adjustments
in respect of which shall be covered by the terms of Section
3(a)(i) above),


 



then and in each such case, the Exercise Price and the number of
Warrant Shares to be obtained upon exercise of this Warrant shall
be adjusted proportionately, and the Holder hereof shall, upon the
exercise of this Warrant, be entitled to receive, in addition to
the number of shares of Common Stock receivable thereupon, and
without payment of any additional consideration therefor, the
amount of stock and other securities and property (including cash
in the cases referred to above) that such Holder would hold on the
date of such exercise had such Holder been the holder of record of
such Common Stock as of the date on which holders of Common Stock
received or became entitled to receive such shares or all other
additional stock and other securities and property. The Exercise
Price and the Warrant Shares, as so adjusted, shall be readjusted
in the same manner upon the happening of any successive event or
events described in this Section 3(a)(ii).


 


(iii)   
Reorganization,
Reclassification, Consolidation, Merger or Sale. If any recapitalization,
reclassification or reorganization of the capital stock of the
Company, or any consolidation or merger of the Company with another
corporation, or the sale of all or substantially all of its assets
or other transaction shall be effected in such a way that holders
of Common Stock shall be entitled to receive stock, securities, or
other assets or property (an “Organic
Change”), then, as a condition of
such Organic Change, lawful and adequate provisions shall be made
by the Company whereby the Holder hereof shall thereafter have the
right to purchase and receive (in lieu of the shares of the Common
Stock of the Company immediately theretofore purchasable and
receivable upon the exercise of the rights represented by this
Warrant) such shares of stock, securities or other assets or
property as may be issued or payable with respect to or in exchange
for a number of outstanding shares of such Common Stock equal to
the number of shares of such stock immediately theretofore
purchasable and receivable assuming the full exercise of the rights
represented by this Warrant. In the event of any Organic Change,
appropriate provision shall be made by the Company with respect to
the rights and interests of the Holder of this Warrant to the end
that the provisions hereof (including, without limitation,
provisions for adjustments of the Exercise Price and of the number
of shares purchasable and receivable upon the exercise of this
Warrant) shall thereafter be applicable, in relation to any shares
of stock, securities or assets thereafter deliverable upon the
exercise hereof. The Company will not affect any such
consolidation, merger or sale unless, prior to the consummation
thereof, the successor corporation (if other than the Company)
resulting from such consolidation or merger or the corporation
purchasing such assets shall assume by written instrument
reasonably satisfactory in form and substance to the Holder
executed and mailed or delivered to the registered Holder hereof at
the last address of such Holder appearing on the books of the
Company, the obligation to deliver to such Holder such shares of
stock, securities or assets as, in accordance with the foregoing
provisions, such Holder may be entitled to purchase. If there is an
Organic Change, then the Company shall cause to be mailed to the
Holder at its last address as it shall appear on the books and
records of the Company, at least 10 calendar days before the
effective date of the Organic Change, a notice stating the date on
which such Organic Change is expected to become effective or close,
and the date as of which it is expected that holders of the Common
Stock of record shall be entitled to exchange their shares for
securities, cash, or other property delivered upon such Organic
Change; provided, that the failure to mail such notice or any
defect therein or in the mailing thereof shall not affect the
validity of the corporate action required to be specified in such
notice. The Holder is entitled to exercise this Warrant during the
10-day period commencing on the date of such notice to the
effective date of the event triggering such notice. In any event,
the successor corporation (if other than the Company) resulting
from such consolidation or merger or the corporation purchasing
such assets shall be deemed to assume such obligation to deliver to
such Holder such shares of stock, securities or assets even in the
absence of a written instrument assuming such obligation to the
extent such assumption occurs by operation of
law.


 



 

6







 






 


(b)    Certificate as to
Adjustments. Upon the
occurrence of each adjustment or readjustment pursuant to this
Section 3, the Company at its expense shall promptly compute such
adjustment or readjustment in accordance with the terms hereof and
furnish to each Holder of this Warrant a certificate setting forth
such adjustment or readjustment and showing in detail the facts
upon which such adjustment or readjustment is based. The Company
shall promptly furnish or cause to be furnished to such Holder a
like certificate setting forth: (i) such adjustments and
readjustments; and (ii) the number of shares and the amount, if
any, of other property which at the time would be received upon the
exercise of the Warrant.


 


(c)    Certain
Events. If any event occurs as
to which the other provisions of this Section 3 are not strictly
applicable but the lack of any adjustment would not fairly protect
the purchase rights of the Holder under this Warrant in accordance
with the basic intent and principles of such provisions, or if
strictly applicable would not fairly protect the purchase rights of
the Holder under this Warrant in accordance with the basic intent
and principles of such provisions, then the Company's Board of
Directors will, in good faith, make an appropriate adjustment to
protect the rights of the Holder; provided,
that no such adjustment pursuant to this Section 3(c) will increase
the Exercise Price or decrease the number of Warrant Shares as
otherwise determined pursuant to this Section
3.


 


4.   
INTENTIONALLY OMITTED.


5.    TRANSFERS AND EXCHANGES OF WARRANT AND WARRANT
SHARES


 


(a)    Registration of
Transfers and Exchanges.
Subject to Section 5(c), upon the Holder’s surrender of this
Warrant, with a duly executed copy of the Form of Assignment
attached as Exhibit B, to the Secretary of the Company at its principal
offices or at such other office or agency as the Company may
specify in writing to the Holder, the Company shall register the
transfer of all or any portion of this Warrant. Upon such
registration of transfer, the Company shall issue a new Warrant, in
substantially the form of this Warrant, evidencing the acquisition
rights transferred to the transferee and a new Warrant, in similar
form, evidencing the remaining acquisition rights not transferred,
to the Holder requesting the transfer.


 


(b)    Warrant Exchangeable
for Different Denominations.
The Holder may exchange this Warrant for a new Warrant or Warrants,
in substantially the form of this Warrant, evidencing in the
aggregate the right to purchase the number of Warrant Shares which
may then be purchased hereunder, each of such new Warrants to be
dated the date of such exchange and to represent the right to
purchase such number of Warrant Shares as shall be designated by
the Holder. The Holder shall surrender this Warrant with duly
executed instructions regarding such re-certification of this
Warrant to the Secretary of the Company at its principal offices or
at such other office or agency as the Company may specify in
writing to the Holder.


 


(c)    Restrictions on
Transfers. This Warrant may not
be transferred at any time without (i) registration under the
Securities Act or (ii) an exemption from such registration and a
written opinion of legal counsel addressed to the Company that the
proposed transfer of the Warrant may be effected without
registration under the Securities Act, which opinion will be in
form and from counsel reasonably satisfactory to the
Company.


 


(d)    Permitted Transfers
and Assignments.
Notwithstanding any provision to the contrary in this Section 5,
the Holder may transfer, with or without consideration, this
Warrant or any of the Warrant Shares (or a portion thereof) to the
Holder’s Affiliates (as such term is defined under Rule 144
of the Securities Act) without obtaining the opinion from counsel
that may be required by Section 5(c)(ii), provided,
that the Holder delivers to the
Company and its counsel certification, documentation, and other
assurances reasonably required by the Company’s counsel to
enable the Company’s counsel to render an opinion to the
Company’s Transfer Agent that such transfer does not violate
applicable securities laws.


 



 

7







 






 


6.    MUTILATED OR MISSING WARRANT
CERTIFICATE


 


If this Warrant is mutilated, lost, stolen or
destroyed, upon request by the Holder, the Company will, at its
expense, issue, in exchange for and upon cancellation of the
mutilated Warrant, or in substitution for the lost, stolen or
destroyed Warrant, a new Warrant, in substantially the form of this
Warrant, representing the right to acquire the equivalent number of
Warrant Shares; provided,
that, as a prerequisite to the issuance of a substitute Warrant,
the Company may require satisfactory evidence of loss, theft or
destruction as well as an indemnity from the Holder of a lost,
stolen or destroyed Warrant.


 


7.    PAYMENT OF TAXES


 


The Company will pay all transfer and stock
issuance taxes attributable to the preparation, issuance and
delivery of this Warrant and the Warrant Shares (and replacement
Warrants) including, without limitation, all documentary and stamp
taxes; provided,
however,
that the Company shall not be required to pay any tax in respect of
the transfer of this Warrant, or the issuance or delivery of
certificates for Warrant Shares or other securities in respect of
the Warrant Shares to any person or entity other than to the
Holder.


 



8.    FRACTIONAL
WARRANT SHARES


 


No
fractional Warrant Shares shall be issued upon exercise of this
Warrant. The Company, in lieu of issuing any fractional Warrant
Share, shall round up the number of Warrant Shares issuable to
nearest whole share.


 


9.    NO STOCK RIGHTS AND LEGEND


 


No
holder of this Warrant, as such, shall be entitled to vote or be
deemed the holder of any other securities of the Company that may
at any time be issuable on the exercise hereof, nor shall anything
contained herein be construed to confer upon the holder of this
Warrant, as such, the rights of a stockholder of the Company or the
right to vote for the election of directors or upon any matter
submitted to stockholders at any meeting thereof, or give or
withhold consent to any corporate action or to receive notice of
meetings or other actions affecting stockholders (except as
provided herein), or to receive dividends or subscription rights or
otherwise (except as provide herein).


 


Each
certificate for Warrant Shares initially issued upon the exercise
of this Warrant, and each certificate for Warrant Shares issued to
any subsequent transferee of any such certificate, shall be stamped
or otherwise imprinted with a legend in substantially the following
form:


 


“THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“ACT”), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH
SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, PLEDGED,
ASSIGNED OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION
STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE ACT AND ANY
APPLICABLE STATE SECURITIES LAWS, OR (2) AN EXEMPTION FROM SUCH
REGISTRATION EXISTS AND THE COMPANY RECEIVES AN OPINION OF COUNSEL
TO THE HOLDER OF SUCH SECURITIES, WHICH COUNSEL AND OPINION ARE
REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH SECURITIES MAY BE
OFFERED, SOLD, PLEDGED, ASSIGNED OR TRANSFERRED IN THE MANNER
CONTEMPLATED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE
ACT OR APPLICABLE STATE SECURITIES LAWS.”


 



 

8







 






 


10.    INTENTIONALLY OMITTED.


 



11.    NOTICES


 


All notices, consents, waivers, and other
communications under this Warrant must be in writing and will be
deemed given to a party when (a) delivered to the appropriate
address by hand or by nationally recognized overnight courier
service (costs prepaid); (b) sent by facsimile or e-mail with
confirmation of transmission by the transmitting equipment; (c)
received or rejected by the addressee, if sent by certified mail,
return receipt requested, if to the registered Holder hereof; or
(d) seven days after the placement of the notice into the mails
(first class postage prepaid), to the Holder at the address,
facsimile number, or e-mail address furnished by the registered
Holder to the Company, or if to the Company, to it at
301 N.
Harrison St., Suite 9F #459, Princeton, NJ 08540, Attn: Frank Pilkiewicz, CEO (or to such other address, facsimile number, or
e-mail address as the Holder or the Company as a party may
designate by notice the other party).


 


12.    SEVERABILITY


 


If
a court of competent jurisdiction holds any provision of this
Warrant invalid or unenforceable, the other provisions of this
Warrant will remain in full force and effect. Any provision of this
Warrant held invalid or unenforceable only in part or degree will
remain in full force and effect to the extent not held invalid or
unenforceable.


 



13.    BINDING
EFFECT


 


This
Warrant shall be binding upon and inure to the sole and exclusive
benefit of the Company, its successors and assigns, the registered
Holder or Holders from time to time of this Warrant and the Warrant
Shares.


 



14.    SURVIVAL
OF RIGHTS AND DUTIES


 


This
Warrant shall terminate and be of no further force and effect on
the earlier of 5:00 P.M., Eastern Time, on the Expiration Date or
the date on which this Warrant has been exercised in
full.


 



 

9







 






 


15.    GOVERNING LAW


 


This
Warrant will be governed by and construed under the laws of the
State of New York without regard to conflicts of laws principles
that would require the application of any other law.


 


16.    DISPUTE RESOLUTION


 


In
the case of a dispute as to the determination of the Exercise Price
or the arithmetic calculation of the Warrant Shares, the Company
shall submit the disputed determinations or arithmetic calculations
via facsimile within two Business Days of receipt of the Notice of
Exercise giving rise to such dispute, as the case may be, to the
Holder. If the Holder and the Company are unable to agree upon such
determination or calculation of the Exercise Price or the Warrant
Shares within three Business Days of such disputed determination or
arithmetic calculation being submitted to the Holder, then the
Company shall, within two Business Days, submit via facsimile (a)
the disputed determination of the Exercise Price to an independent,
reputable investment bank selected by the Company and approved by
the Holder or (b) the disputed arithmetic calculation of the
Warrant Shares to the Company’s independent, outside
accountant. The Company shall cause at its expense the investment
bank or the accountant, as the case may be, to perform the
determinations or calculations and notify the Company and the
Holder of the results no later than ten (10) Business Days from the
time it receives the disputed determinations or calculations. Such
investment bank’s or accountant’s determination or
calculation, as the case may be, shall be binding upon all parties
absent demonstrable error.


 


17.    NOTICES OF RECORD DATE


 


Upon
(a) any establishment by the Company of a record date of the
holders of any class of securities for the purpose of determining
the holders thereof who are entitled to receive any dividend or
other distribution, or right or option to acquire securities of the
Company, or any other right, or (b) any capital reorganization,
reclassification, recapitalization, merger or consolidation of the
Company with or into any other corporation, any transfer of all or
substantially all the assets of the Company, or any voluntary or
involuntary dissolution, liquidation or winding up of the Company,
or the sale, in a single transaction, of a majority of the
Company’s voting stock (whether newly issued, or from
treasury, or previously issued and then outstanding, or any
combination thereof), the Company shall mail to the Holder at least
ten (10) Business Days, or such longer period as may be required by
law, prior to the record date specified therein, a notice
specifying (i) the date established as the record date for the
purpose of such dividend, distribution, option or right and a
description of such dividend, option or right, (ii) the date on
which any such reorganization, reclassification, transfer,
consolidation, merger, dissolution, liquidation or winding up, or
sale is expected to become effective and (iii) the date, if any,
fixed as to when the holders of record of Common Stock shall be
entitled to exchange their shares of Common Stock for securities or
other property deliverable upon such reorganization,
reclassification, transfer, consolation, merger, dissolution,
liquidation or winding up.


 



 

10







 






 


18.    RESERVATION OF SHARES


 


The
Company shall reserve and keep available out of its authorized but
unissued shares of Common Stock for issuance upon the exercise of
this Warrant, free from pre-emptive rights, such number of shares
of Common Stock for which this Warrant shall from time to time be
exercisable. The Company will take all such reasonable action as
may be necessary to assure that such Warrant Shares may be issued
as provided herein without violation of any applicable law or
regulation. Without limiting the generality of the foregoing, the
Company covenants that it will use commercially reasonable efforts
to take all such action as may be necessary or appropriate in order
that the Company may validly and legally issue fully paid and
nonassessable Warrant Shares upon the exercise of this Warrant and
use commercially reasonable efforts to obtain all such
authorizations, exemptions or consents, including but not limited
to consents from the Company’s stockholders or Board of
Directors or any public regulatory body, as may be necessary to
enable the Company to perform its obligations under this
Warrant.


 


19.    NO THIRD PARTY RIGHTS


 


This
Warrant is not intended, and will not be construed, to create any
rights in any parties other than the Company and the Holder, and no
person or entity may assert any rights as third-party beneficiary
hereunder.


 


 



[SIGNATURE PAGE FOLLOWS]


 




 

11








 






 


IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly
executed as of the date first set forth above.


 


 



ADGERO BIOPHARMACEUTICALS HOLDINGS,
INC.


 


 


 



By: ___________________________



Name: Frank
Pilkiewicz



Title: Chief Executive Officer


 


 



12








 










 



EXHIBIT A


 



NOTICE OF EXERCISE


 



(To be executed by the Holder of Warrant if such Holder desires to
exercise Warrant)


 



To Adgero Biopharmaceuticals Holdings, Inc.:


 


The undersigned hereby irrevocably elects to
exercise this Warrant and to purchase thereunder,
___________________ full shares of Adgero Biopharmaceuticals
Holdings, Inc. common stock issuable
upon exercise of the Warrant and delivery of:


 


(1) $_________
(in cash as provided for in the foregoing Warrant) and any
applicable taxes payable by the undersigned pursuant to such
Warrant; and


 


(2) __________
shares of Common Stock (pursuant to a Cashless Exercise in
accordance with Section 1(b)(ii) of the Warrant) (check here if the
undersigned desires to deliver an unspecified number of shares
equal the number sufficient to effect a Cashless Exercise
[___]).


 


The
undersigned requests that certificates for such shares be issued in
the name of:


 



_________________________________________



(Please print name, address and social security or federal
employer



identification number (if applicable))


 



_________________________________________


 



_________________________________________


 


The
undersigned hereby affirms that the undersigned is an accredited
investor as defined under Rule 501 of Regulation D of the
Securities Act of 1933.   If the Holder cannot make the
foregoing affirmation because it is factually incorrect, it shall
be a condition to the exercise of the Warrant that the Company
receive such other representations as the Company considers
necessary, acting reasonably, to assure the Company that the
issuance of securities upon exercise of this Warrant shall not
violate any United States or other applicable securities
laws.


 


If
the shares issuable upon this exercise of the Warrant are not all
of the Warrant Shares which the Holder is entitled to acquire upon
the exercise of the Warrant, the undersigned requests that a new
Warrant evidencing the rights not so exercised be issued in the
name of and delivered to:


 



_________________________________________



(Please print name, address and social security or federal
employer



identification number (if applicable))


 



_________________________________________


 



_________________________________________


 


Name
of Holder (print): ________________________


(Signature):
___________________________________


(By:)
_________________________________________


(Title:)
________________________________________


Dated:
________________________________________



13








 






 



EXHIBIT B


 



FORM OF ASSIGNMENT


 


FOR
VALUE RECEIVED, ___________________________________ hereby sells,
assigns and transfers to each assignee set forth below all of the
rights of the undersigned under the Warrant (as defined in and
evidenced by the attached Warrant) to acquire the number of Warrant
Shares set opposite the name of such assignee below and in and to
the foregoing Warrant with respect to said acquisition rights and
the shares issuable upon exercise of the Warrant:


 


 


	


Name of Assignee

	


Address

	


Number of Shares


	
 

	
 

	
 


	
 

	
 

	
 


	
 

	
 

	
 


	
 

	
 

	
 







 


 


If
the total of the Warrant Shares are not all of the Warrant Shares
evidenced by the foregoing Warrant, the undersigned requests that a
new Warrant evidencing the right to acquire the Warrant Shares not
so assigned be issued in the name of and delivered to the
undersigned.


 


 


Name
of Holder (print): ________________________


(Signature):
___________________________________


(By:)
_________________________________________


(Title:)
________________________________________


Dated:
________________________________________


 


 


 




 

14